sefullness of non-invasive biomarkers in the treatment wiht bronchial asthma
Phase 4
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000001768
- Lead Sponsor
- Third Department of Internal medicine, Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Obstructive pulmonary disease; COPD, bronchiectasis, choronic bbronchitis 2. Tuberculosis, other respiratory infection 3. Allergy for salbutamol 4. Pregnancy and lactation 5. Moderate and severe asthma exacerbation 6. inappropriate patients from the doctor's viewpoint
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Routine respiratory function tests: spirometry,body plethysmography and closing volume at atable period, before and 15min after inhaled bronchodilator during mild exacerbation. 2.Non-invasive biomarker; impulse oscillometry: R5,R20,R5-R20,X5,AX, and exhaled nitric oxide at stable period, before and 15min after inhaled bronchodilator during mild exacerbation.
- Secondary Outcome Measures
Name Time Method Scores of questionnaires for QO